Metformin may be considered either a direct or LKB-1/AMPK-mediated modulator of SIRT1 expression, able to alleviate hyperglycemia-caused endothelial senescence and cell death (Figure 4). This evidence concerns the gene SIRT1 and Hyperglycemia.